Emerson Electric (EMR) Financials

Emerson Electric (NYSE: EMR) has shown a pattern of solid profitability and durable cash generation across the last four years of quarterly reports. Below are the key takeaways focused on trends in income, cash flow, and the balance sheet, with items organized to highlight positives first, then neutral, then negatives.

• Per-share profitability and shareholder returns: In the latest quarter (Q1 2026), basic EPS was 1.08 and diluted EPS was 1.07, with cash dividends per share of 0.555. This reflects continued earnings power and an active capital-return policy.
• Robust operating cash flow: EMR has generated substantial operating cash flow across quarters, with net cash from continuing operating activities frequently in the $0.7–1.1 billion range (example: Q4 2025 CFO ≈ $1.073B; Q3 2025 ≈ $1.061B; Q2 2025 ≈ $0.826B; Q1 2025 ≈ $1.01B).
• Large, stable revenue base supports profitability: Quarterly operating revenue typically sits above $4.0 billion in recent years, providing a stable base to support gross and operating profitability.
• Dividend credibility and growth: The company has maintained and recently increases cash dividends per share (0.525–0.555 range), signaling ongoing capital-return confidence to owners.
• Solid balance-sheet capitalization: At Q1 2026, total assets were about $41.9B, total liabilities about $21.6B, and total equity about $20.3B, indicating a well-balanced capital structure with a sizable equity base relative to liabilities.
• Debt activity and capital access: EMR shows substantial debt financing in some periods (e.g., issuance of debt around $3.37B in Q1 2026), suggesting strong market access to fund needs. The net effect on liquidity depends on how the proceeds are deployed.
• High goodwill and intangible assets: Goodwill typically ranges around $18–19B and intangible assets around $6–11B over the period, reflecting prior acquisitions. This creates potential impairment risk if market conditions deteriorate, though it's not an immediate cash-flow concern.
• Cash balance volatility: Cash & equivalents have ranged from about $1.7B to $3.6B across periods, indicating liquidity has been strong at times but has fluctuated, which may warrant watchfulness if cash needs rise.
• Financing cash outflows visible in quarters: Net cash from financing activities has frequently been negative (for example Q4 2025 ≈ -$1.49B; Q1 2026 ≈ -$0.36B), driven by dividends and debt repayments outpacing new issuances in multiple periods.
• Leverage edge of liabilities vs. equity: In several periods, total liabilities have been near or slightly above total equity (for example, Q1 2026: liabilities ≈ $21.65B vs equity ≈ $20.28B), indicating a modest tilt toward higher leverage that should be monitored if revenue or cash flow slows.